
The Cleartest Strep B is a qualitative immunological rapid test that detects group B streptococci from vaginal or rectal swabs in pregnant women and from skin swabs in newborns. This test is frequently used to rule out a possible infection shortly before birth and to establish a rapid diagnosis. The test should be performed no earlier than 3 weeks before delivery and is not part of routine prenatal care.
Areas of application:
-
Early detection in pregnant women: For the rapid diagnosis of group B streptococci (GBS) in pregnant women shortly before birth.
-
Newborn screening: To rule out streptococcal infection in newborns
-
Preventive diagnostics: Early detection of infections to prevent transmission to the newborn during birth.
-
Medical examinations: Ideal for use in maternity clinics and practices to prepare for childbirth
Advantages at a glance:
-
Fast results: Test results available in just 10 minutes
-
High detection limit: Detects up to 1 x 10^7 Org/ml group B streptococci
-
Early diagnosis: Helps to rule out possible infections in pregnant women early on and protect the health of the newborn.
-
Includes positive control: The test includes a positive control to ensure correct execution and evaluation.
-
Easy to use: Quick and straightforward to perform, no special laboratory requirements necessary
Further information:
-
The test is particularly useful in preventing the transmission of streptococci to the newborn during birth, which can lead to serious infections.
-
Important note: The test should be carried out no later than 3 weeks before birth in order to initiate timely treatment.
Delivery information: 10 tests
PZN: 10629182
WEEE number:
Assistive device number:
Manufacturer:
Servoprax GmbH
Am Marienbusch 9
46485 Wesel
Deutschland
Tel: +49 281 95283-05283-0
Email: info@servoprax.de
VAT ID number: DE120980351